Sarepta Therapeutics to Present Company Overview at the Cowen and Company 37th Annual Health Care Conference
March 02 2017 - 6:00PM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial stage
developer of innovative RNA-targeted therapeutics, today announced
that it is scheduled to present at the Cowen and Company 37th
Annual Health Care Conference in Boston,
MA on Wednesday, March 8 at 8:00 a.m.
ET. Edward Kaye, Sarepta's chief executive officer, will be
the presenter at the fireside chat.
The presentation will be webcast live on the investor relations
section of the Sarepta Therapeutics website
at www.sarepta.com and will be archived under the events
and presentations section following the presentation for 90 days.
Please connect to Sarepta's website several minutes prior to the
start of the broadcast to ensure adequate time for any software
download that may be necessary.
About Sarepta TherapeuticsSarepta
Therapeutics is a commercial-stage biopharmaceutical company
focused on the discovery and development of unique RNA-targeted
therapeutics for the treatment of rare neuromuscular diseases. The
Company is primarily focused on rapidly advancing the development
of its potentially disease-modifying Duchenne muscular dystrophy
(DMD) drug candidates. For more information, please visit us
at www.sarepta.com.
Internet Posting of InformationWe routinely
post information that may be important to investors in the 'For
Investors' section of our web site at www.sarepta.com. We
encourage investors and potential investors to consult our website
regularly for important information about us.
Sarepta Therapeutics, Inc.
Media and Investors:
Ian Estepan, 617-274-4052
iestepan@sarepta.com
or
W2O Group
Brian Reid, 212-257-6725
breid@w2ogroup.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Sep 2023 to Sep 2024